Citrus aurantium L. var. amara Engl. inhibited lipid accumulation in 3T3-L1 cells and Caenorhabditis elegans and prevented obesity in high-fat diet-fed mice. (September 2019)
- Record Type:
- Journal Article
- Title:
- Citrus aurantium L. var. amara Engl. inhibited lipid accumulation in 3T3-L1 cells and Caenorhabditis elegans and prevented obesity in high-fat diet-fed mice. (September 2019)
- Main Title:
- Citrus aurantium L. var. amara Engl. inhibited lipid accumulation in 3T3-L1 cells and Caenorhabditis elegans and prevented obesity in high-fat diet-fed mice
- Authors:
- Shen, Chun-Yan
Wan, Lin
Wang, Tian-Xing
Jiang, Jian-Guo - Abstract:
- Graphical abstract: Abstract: Natural products with anti-obesity effects and few side effects have attracted great attention recently. Citrus aurantium L. var. amara Engl. (CAVA) is popularly consumed as an edible and medicinal resource in China. However, its anti-obesity effects were poorly understood. The anti-obesity effects of CAVA extracts were systematically evaluated using 3T3-L1 cells, Caenorhabditis elegans ( C. elegans ) and high fat diet (HFD)-fed mice. Flavonoid-rich (EA) extracts with neohesperidin, hesperidin and naringin comprising 32.15%, were isolated from CAVA. EA extracts treatment significantly inhibited differentiation of 3T3-L1 preadipocytes by modulating lipid metabolism-related mediators. EA extracts supplementation also inhibited antioxidant responses in C. elegans by decreasing reactive oxygen species generation and malonaldehyde value, and increasing superoxide dismutase content. EA extracts feeding markedly decreased triglyceride (TG) content, and affected expression of genes involved in lipid and glucose metabolism in wild type C. elegans . TG content in mdt-15 (XA7702) mutants was not decreased by EA extracts administration, suggesting that EA extracts treatment might inhibit lipid accumulation in C. elegans dependent on mdt-15 . EA extracts intervention further reduced body weight gain and modulated plasma biochemical parameters in HFD-fed mice. EA extracts treatment prevented HFD-induced epididymal adipose hypertrophy, liver oxidative injuriesGraphical abstract: Abstract: Natural products with anti-obesity effects and few side effects have attracted great attention recently. Citrus aurantium L. var. amara Engl. (CAVA) is popularly consumed as an edible and medicinal resource in China. However, its anti-obesity effects were poorly understood. The anti-obesity effects of CAVA extracts were systematically evaluated using 3T3-L1 cells, Caenorhabditis elegans ( C. elegans ) and high fat diet (HFD)-fed mice. Flavonoid-rich (EA) extracts with neohesperidin, hesperidin and naringin comprising 32.15%, were isolated from CAVA. EA extracts treatment significantly inhibited differentiation of 3T3-L1 preadipocytes by modulating lipid metabolism-related mediators. EA extracts supplementation also inhibited antioxidant responses in C. elegans by decreasing reactive oxygen species generation and malonaldehyde value, and increasing superoxide dismutase content. EA extracts feeding markedly decreased triglyceride (TG) content, and affected expression of genes involved in lipid and glucose metabolism in wild type C. elegans . TG content in mdt-15 (XA7702) mutants was not decreased by EA extracts administration, suggesting that EA extracts treatment might inhibit lipid accumulation in C. elegans dependent on mdt-15 . EA extracts intervention further reduced body weight gain and modulated plasma biochemical parameters in HFD-fed mice. EA extracts treatment prevented HFD-induced epididymal adipose hypertrophy, liver oxidative injuries and steatosis. EA extracts administration also strongly prevented HFD-induced reduction of gut microbial diversity, decreased the Firmicutes-to-Bacteroidetes ratio and the Erysipelotrichaceae abundance, and enhanced the Bifidobacteriace abundance in HFD-fed mice. EA extracts from blossoms of CAVA were excellent antiobesogenic candidates that acted through multiple mechanisms that acted simultaneously. … (more)
- Is Part Of:
- Pharmacological research. Volume 147(2019)
- Journal:
- Pharmacological research
- Issue:
- Volume 147(2019)
- Issue Display:
- Volume 147, Issue 2019 (2019)
- Year:
- 2019
- Volume:
- 147
- Issue:
- 2019
- Issue Sort Value:
- 2019-0147-2019-0000
- Page Start:
- Page End:
- Publication Date:
- 2019-09
- Subjects:
- CAVA C. aurantium Citrus aurantium -- C. elegans Caenorhabditis elegans Citrus aurantium L. var. amara Engl -- HFD high-fat diet -- EA ethyl acetate -- FBS fetal bovine serum -- DMI diff ;erentiation medium -- IBMX 0.5 mM 3-isobutyl-methylxanthine -- DEX dexamethasone -- TG Triacylglycerol -- TCHO total cholesterol -- LDL-C LDL-cholesterol -- HDL-C HDL-cholesterol -- H2DCFDA 2′, 7′-dichlorodihydro-fluorescein diacetate -- HE hematoxylin and eosin -- C/EBPα CCAAT/enhancer binding protein α -- Pref-1 preadipocyte factor 1 -- FAS fatty acid synthase -- ROS reactive oxygen species -- MDA malonaldehyde -- SOD superoxide dismutase -- CAT catalase -- PBS phosphate buffered saline -- NGM nematode growth medium -- PPARγ peroxisome proliferator-activated receptor-gamma -- ACOX1 acyl-coA oxidase 1 -- UCP2 uncoupling protein 2 -- OTUs operational taxonomic units -- LEfSe linear discriminant analysis effect size
Citrus aurantium L. var. amara Engl. -- Caenorhabditis elegans -- 3T3-L1 -- High fat diet -- Obesity
Pharmacology -- Periodicals
Pharmacology -- Periodicals
Research -- Periodicals
Médicaments -- Recherche -- Périodiques
Pharmacologie -- Périodiques
615.105 - Journal URLs:
- http://www.sciencedirect.com/science/journal/10436618 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.phrs.2019.104347 ↗
- Languages:
- English
- ISSNs:
- 1043-6618
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6446.550000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 11642.xml